Volterra Technologies’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,611
Closed -$565K 356
2025
Q4
$565K Buy
1,611
+1,131
+236% +$382K 0.06% 234
2025
Q3
$155K Sell
480
-1,133
-70% -$352K 0.01% 311
2025
Q2
$627K Buy
+1,613
New +$649K 0.08% 237

Other funds holding ELV

Volterra Technologies's ELV Position: Q1 2026 in Review

Volterra Technologies sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,611 shares — an estimated $565K sold.

Volterra Technologies first reported a position in ELV in Q2 2025 and held it in 3 quarters. The position peaked at $627K in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Volterra Technologies reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Volterra Technologies sold 1,611 Elevance Health shares in Q1 2026, an estimated $565K.
  • Volterra Technologies first reported a position in Elevance Health in Q2 2025 and held it in 3 quarters.
  • Volterra Technologies's Elevance Health position peaked at $627K in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Volterra Technologies's 13F filing for Q1 2026, filed 14 May 2026.